Prosecution Insights
Prosecution Insights
Tech Center 4100 • Art Units: 1618 4100
This examiner grants 23% of resolved cases
Nissa M. Westerberg is a patent examiner assigned to Art Unit 1618 within Tech Center 4100. The examiner's professional record includes 907 resolved cases. The data indicates an allowance rate of 23.3% for these applications. This figure serves as a primary indicator of the probability of success for cases on this docket. Additionally, the median days to allowance is 1569, which establishes a specific timeframe for the prosecution process. These metrics offer a foundational understanding of the examiner's approach to patent applications.
The interview lift for this examiner is 36.8%. This 36.8% lift shows the change in the likelihood of allowance when an interview is conducted compared to the 23.3% base rate. With 907 resolved cases, the data provides a view of the examiner's historical performance. The 1569-day median pendency is a key metric for managing client expectations regarding the duration of the patent application process in Tech Center 4100. Practitioners should evaluate the allowance rate and the interview lift to determine the most effective strategy for their specific cases.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18745888 | COPPER-64 COMPOSITIONS AND PURIFICATION PROCESSES FOR THE PREPARATION OF NOVEL COPPER-64 COMPOSITIONS | Non-Final OA | Curium US LLC |
| 18354581 | RADIOPHARMACEUTICAL COMPOSITIONS OF COPPER FOR TARGETED MOLECULAR IMAGING | Non-Final OA | Curium US LLC |
| 17795143 | FLUORESCENT SILICA NANOPARTICLES AND METHOD FOR MANUFACTURING FLUORESCENT SILICA NANOPARTICLES | Non-Final OA | Konica Minolta, Inc. |
| 18424697 | STEREOCOMPLEX OF OLIGOLACTIC ACID CONJUGATES IN MICELLES FOR IMPROVED PHYSICAL STABILITY AND ENHANCED ANTITUMOR EFFICACY | Non-Final OA | Wisconsin Alumni Research Foundation |
| 17308599 | CATIONIC MUCIC ACID POLYMER-BASED DELIVERY SYSTEMS | Final Rejection | California Institute Of Technology |
| 17092215 | REMOTE-CONTROLLED IMAGE-GUIDED DRUG DELIVERY VIA ULTRASOUND-MODULATED MOLECULAR DIFFUSION | Non-Final OA | California Institute of Technology |
| 17445285 | ENHANCING SUBCUTANEOUS INJECTION AND TARGET TISSUE ACCUMULATION OF NANOPARTICLES VIA CO-ADMINISTRATION WITH MACROPINOCYTOSIS INHIBITORY NANOPARTICLES (MINP) | Final Rejection | Northwestern University |
| 18797888 | Octreotide Depot Formulation with Constantly High Exposure Levels | Non-Final OA | Novartis AG |
| 18166390 | METHODS AND COMPOSITION FOR DYE-BASED ENCODING AND QUANTIFICATION | Final Rejection | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA |
| 17403157 | COSMETIC COMPOSITIONS | Final Rejection | L'Oreal |
| 18904575 | Compositions and Methods for Targeting Lipid Nanoparticle Therapeutics to Stem Cells | Final Rejection | The Trustees of the University of Pennsylvania |
| 18575219 | WATER-SOLUBLE NERVE DYES FOR IN VIVO NERVE-SPECIFIC IMAGING | Non-Final OA | Oregon Health & Science University |
| 18551786 | ORAL DELIVERY OF SILICA/ALUMINOSILICATE NANOPARTICLES | Non-Final OA | Cornell University |
| 17606226 | COMPOSITIONS AND METHODS OF IMMUNODEPLETION FOR THE TREATMENT OF MALIGNANT AND NON-MALIGNANT HEMATOLOGICAL DISEASES | Non-Final OA | ACTINIUM PHARMACEUTICALS, INC. |
| 18570180 | Contrast agent for magnetic resonance imaging | Non-Final OA | Betavist GmbH |
| 18306223 | COMPOSITIONS, CONTAINERS, AND METHODS RELATED TO FLAVYLIUM EXCIPIENTS | Non-Final OA | Natural Extraction Systems, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy